Uveitis

• 

  Subject Areas on Research

  • 2019 American College of Rheumatology/Arthritis Foundation Guideline for the Screening, Monitoring, and Treatment of Juvenile Idiopathic Arthritis-Associated Uveitis. 
  • 2019 American College of Rheumatology/Arthritis Foundation Guideline for the Screening, Monitoring, and Treatment of Juvenile Idiopathic Arthritis-Associated Uveitis. 
  • 2021 American College of Rheumatology Guideline for the Treatment of Juvenile Idiopathic Arthritis: Recommendations for Nonpharmacologic Therapies, Medication Monitoring, Immunizations, and Imaging. 
  • 2021 American College of Rheumatology Guideline for the Treatment of Juvenile Idiopathic Arthritis: Recommendations for Nonpharmacologic Therapies, Medication Monitoring, Immunizations, and Imaging. 
  • 2021 American College of Rheumatology Guideline for the Treatment of Juvenile Idiopathic Arthritis: Therapeutic Approaches for Oligoarthritis, Temporomandibular Joint Arthritis, and Systemic Juvenile Idiopathic Arthritis. 
  • 2021 American College of Rheumatology Guideline for the Treatment of Juvenile Idiopathic Arthritis: Therapeutic Approaches for Oligoarthritis, Temporomandibular Joint Arthritis, and Systemic Juvenile Idiopathic Arthritis. 
  • A clinical and histopathological review of intermediate uveitis ("pars planitis"). 
  • A murine model of congenital toxoplasmic retinochoroiditis. 
  • Acyclovir-resistant herpes simplex virus keratouveitis after penetrating keratoplasty. 
  • Adalimumab for prevention of uveitic flare in patients with inactive non-infectious uveitis controlled by corticosteroids (VISUAL II): a multicentre, double-masked, randomised, placebo-controlled phase 3 trial. 
  • Adalimumab in Active and Inactive, Non-Infectious Uveitis: Global Results from the VISUAL I and VISUAL II Trials. 
  • Adalimumab in Patients with Active Noninfectious Uveitis. 
  • Adverse events after intravitreal triamcinolone in patients with and without uveitis. 
  • Aflibercept-related sterile inflammation. 
  • An intravitreal device providing sustained release of cyclosporine and dexamethasone. 
  • Assessment of the Accuracy of Using ICD-9 Codes to Identify Uveitis, Herpes Zoster Ophthalmicus, Scleritis, and Episcleritis. 
  • Association Between Thyroid Disease and Uveitis: Results From the Pacific Ocular Inflammation Study. 
  • Association between Smoking and Uveitis: Results from the Pacific Ocular Inflammation Study. 
  • Association between statin use and uveitis: results from the Pacific Ocular Inflammation study. 
  • Association of Disorganization of Retinal Inner Layers With Visual Acuity In Eyes With Uveitic Cystoid Macular Edema. 
  • Asymptomatic transient uveitis in children with inflammatory bowel disease. 
  • Autoantibodies to DEK oncoprotein in human inflammatory disease. 
  • Central corneal thickness in children and adolescents with pediatric glaucoma and eye disorders at risk of developing glaucoma. 
  • Characterization of Ebola Virus-Associated Eye Disease. 
  • Choroidal imaging in uveitis: An update. 
  • Chronic multifocal retinal infiltrates in patients infected with human immunodeficiency virus. 
  • Combined Ahmed Glaucoma Valve Placement, Intravitreal Fluocinolone Acetonide Implantation and Cataract Extraction for Chronic Uveitis. 
  • Combined fluocinolone acetonide intraocular delivery system insertion, phacoemulsification, and intraocular lens implantation for severe uveitis. 
  • Combined medical and surgical therapy for complicated cases of peripheral uveitis. 
  • Comparison of Modified Posterior Sub-Tenon's vs. Trans-Septal Triamcinolone Injection for Non-infectious Uveitis. 
  • Cost-effectiveness of alternative strategies for interferon-γ release assays and tuberculin skin test in tuberculous uveitis. 
  • Cyclophosphamide therapy of peripheral uveitis. 
  • Diagnosis and Management of Idiopathic Persistent Iritis after Cataract Surgery (IPICS). 
  • Diagnostic vitrectomy in the management of ocular disease. 
  • Diagnostic yield of vitreous biopsy in presumed sarcoidosis-related posterior segment inflammation. 
  • Differential effectiveness of etanercept and infliximab in the treatment of ocular inflammation. 
  • Diffuse infiltrating retinoblastoma simulating uveitis in a 7-year-old boy. 
  • Dissociations of the Fluocinolone Acetonide Implant: The Multicenter Uveitis Steroid Treatment (MUST) Trial and Follow-up Study. 
  • Distinguishing Blau Syndrome from Systemic Sarcoidosis. 
  • Effect of an intravitreal cyclosporine implant on experimental uveitis in horses. 
  • Efficacy of low-release-rate fluocinolone acetonide intravitreal implants to treat experimental uveitis. 
  • Endogenous IL-12 is required for induction and expression of experimental autoimmune uveitis. 
  • Endotoxin-induced uveitis in the rat: observations on altered vascular permeability, clinical findings, and histology. 
  • Enthesitis-related arthritis is associated with higher pain intensity and poorer health status in comparison with other categories of juvenile idiopathic arthritis: the Childhood Arthritis and Rheumatology Research Alliance Registry. 
  • Epithelial implantation membrane on the iris surface following cataract extraction with report of two cases. 
  • Expression of a chemokine by ciliary body epithelium in horses with naturally occurring recurrent uveitis and in cultured ciliary body epithelial cells. 
  • Extravascular plasminogen activator and inhibitor activities detected at the site of a chronic mycobacterial-induced inflammation. 
  • Exudative retinal detachment and retinitis associated with acquired syphilitic uveitis. 
  • Factors associated with reduced infliximab exposure in the treatment of pediatric autoimmune disorders: a cross-sectional prospective convenience sampling study. 
  • Fluocinolone acetonide sustained drug delivery device to treat severe uveitis. 
  • Glaucoma associated with uveitis. 
  • Health status of patients with juvenile rheumatoid arthritis at 1 and 5 years after diagnosis. 
  • IFN-gamma-deficient mice develop experimental autoimmune uveitis in the context of a deviant effector response. 
  • Immune mechanisms in inflammatory and degenerative eye disease. 
  • Incidence and prevalence of uveitis: results from the Pacific Ocular Inflammation Study. 
  • Infliximab to treat chronic noninfectious uveitis in children: retrospective case series with long-term follow-up. 
  • Interleukin 12 protects from a T helper type 1-mediated autoimmune disease, experimental autoimmune uveitis, through a mechanism involving interferon gamma, nitric oxide, and apoptosis. 
  • Interobserver Agreement Among Uveitis Experts on Uveitic Diagnoses: The Standardization of Uveitis Nomenclature Experience. 
  • Intraocular pressure in patients with uveitis treated with fluocinolone acetonide implants. 
  • Is This a 737 Max Moment for Brolucizumab? 
  • July consultation #4. 
  • Lack of consensus in the diagnosis and treatment for ocular tuberculosis among uveitis specialists. 
  • MUST Beg to Differ. 
  • Medication use in juvenile uveitis patients enrolled in the Childhood Arthritis and Rheumatology Research Alliance Registry. 
  • Mice deficient in inducible nitric oxide synthase are susceptible to experimental autoimmune uveoretinitis. 
  • Monocyte-induced cytokine expression in cultured human retinal pigment epithelial cells. 
  • Morphology of the fibrinogen exudate during evolution of a mycobacterial-induced murine eye granuloma. 
  • New and emerging treatments for patients with uveitis. 
  • Ocular complications after anti-vascular endothelial growth factor therapy in Medicare patients with age-related macular degeneration. 
  • Ophthalmologic examinations in children with juvenile rheumatoid arthritis. 
  • Optical Coherence Tomography Anatomic and Temporal Biomarkers in Uveitic Macular Edema. 
  • Oral Macrolides for the Dermatologic Manifestations of Blau Syndrome. 
  • Outcome of Treatment of Uveitic Macular Edema: The Multicenter Uveitis Steroid Treatment Trial 2-Year Results. 
  • Pars plana vitrectomy, fluocinolone acetonide implantation, and silicone oil infusion for the treatment of chronic, refractory uveitic hypotony. 
  • Periocular Triamcinolone vs. Intravitreal Triamcinolone vs. Intravitreal Dexamethasone Implant for the Treatment of Uveitic Macular Edema: The PeriOcular vs. INTravitreal corticosteroids for uveitic macular edema (POINT) Trial. 
  • Profile of adalimumab and its potential in the treatment of uveitis. 
  • Proposed outcome measures for prospective clinical trials in juvenile idiopathic arthritis-associated uveitis: a consensus effort from the multinational interdisciplinary working group for uveitis in childhood. 
  • Radical anterior segment surgery for epithelial invasion of the anterior chamber: report of three cases. 
  • Retinal Vasculitis and Intraocular Inflammation after Intravitreal Injection of Brolucizumab. 
  • Retinal nerve fiber layer thickness measurements: uveitis, a major confounding factor. 
  • Review: implants. 
  • Role of Disorganization of Retinal Inner Layers as an Optical Coherence Tomography Biomarker in Diabetic and Uveitic Macular Edema. 
  • Safety and Effectiveness of Adalimumab in Patients With Polyarticular Course of Juvenile Idiopathic Arthritis: STRIVE Registry Seven-Year Interim Results. 
  • Sarcoidosis and its ophthalmic manifestations. 
  • Sequential Sterile Intraocular Inflammation Associated With Consecutive Intravitreal Injections of Aflibercept and Ranibizumab. 
  • Seven-Year Outcomes of Uveitic Macular Edema: The Multicenter Uveitis Steroid Treatment Trial and Follow-up Study Results. 
  • Sterile endophthalmitis after intravitreal triamcinolone: a possible association with uveitis. 
  • Sugiura's sign. Perilimbal vitiligo in the Vogt-Koyanagi-Harada syndrome. 
  • Surgical drainage of chronic serous retinal detachment associated with uveitis. 
  • Surgical outcomes in childhood uveitic glaucoma. 
  • Sustained Release Corticosteroid Therapy for Noninfectious Uveitis. 
  • T cell activation within different intraocular compartments during experimental uveitis. 
  • Tgf-beta inhibits activation and uveitogenicity of primary but not of fully polarized retinal antigen-specific memory-effector T cells. 
  • The ocular manifestations of Wegener's granulomatosis. Fifteen years experience and review of the literature. 
  • The use of silicone oil in uveitis and hypotony. 
  • Therapy for ocular toxoplasmosis. 
  • Treatment of juvenile idiopathic arthritis-associated uveitis: challenges and update. 
  • Use of tumor necrosis factor inhibitors in uveitis. 
  • Uveitis and arthritis: experimental models and clinical correlates. 
  • Uveitis and retinal vasculitis in acute experimental allergic encephalomyelitis in the Lewis rat: an ultrastructural study. 
  • Uveitis in children. 
  • Uveitis in the elderly: epidemiological data from the National Long-term Care Survey Medicare Cohort. 
  • Uveitis in the southeastern United States. 
  • Uveitis with neurological manifestations. 
  • Visual Acuity in Retinal Vein Occlusion, Diabetic, and Uveitic Macular Edema: Central Subfield Thickness and Ellipsoid Zone Analysis. 
• 

  Keywords of People

  • Cianciolo, George James, Associate Professor Emeritus of Pathology, Pathology
  • Mruthyunjaya, Prithvi, Adjunct Associate Professor in the Department of Ophthalmology, Ophthalmology, Vitreoretinal Diseases & Surgery
  • Muir, Kelly Walton, Associate Professor of Ophthalmology, Ophthalmology, Glaucoma
  • Schanberg, Laura Eve, Professor of Pediatrics, Pediatrics, Rheumatology
  • Stinnett, Sandra Sue, Associate Professor of Biostatistics & Bioinformatics, Biostatistics & Bioinformatics